Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.
The figures, for anyone assembling their own picture. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.
Following on from NicoleRaleigh — and this may be the naive question:
What a vetting checklist should actually contain, as opposed to a list of things that are easy to fake?
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsTirzTom said:Say what you would expect to see if you were wrong, before you look.
Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak. People who dose late are not losing a peak, they are letting the trough fall, and the appetite effect tracks the trough.
Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Carry on.